SCI Pharmtech, Inc. (TPE: 4119)

SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	846.82	942.06	166.83	332.23	633.03	553.56
Trading Asset Securities	64.63	89	97.55	360.4	-	466.03
Cash & Short-Term Investments	911.46	1,031	264.37	692.63	633.03	1,020
Cash Growth	291.21%	290.00%	-61.83%	9.42%	-37.91%	28.85%
Accounts Receivable	368.81	307.37	173.57	82.98	337.75	352.4
Other Receivables	0.01	0.15	31.1	265.59	519.65	-
Receivables	368.82	307.52	204.67	348.56	857.4	352.4
Inventory	635.27	529.53	513.43	294.18	380.88	527.08
Other Current Assets	104.01	85.13	59.93	61.93	47.5	36.95
Total Current Assets	2,020	1,953	1,042	1,397	1,919	1,936
Property, Plant & Equipment	3,943	3,912	3,194	2,100	1,503	1,880
Long-Term Investments	226.75	241.62	208.04	124.97	753.65	137.33
Other Intangible Assets	41.94	46.15	54.58	60.29	41.32	47.66
Long-Term Deferred Tax Assets	153.28	153.28	167.25	241.55	263.55	57.24
Other Long-Term Assets	448.17	384.69	294.11	265.64	89.89	23.25
Total Assets	6,832	6,691	4,961	4,190	4,570	4,081
Accounts Payable	51.91	44.25	48.64	33.78	80.88	94.3
Accrued Expenses	30.48	110.72	128.35	121.46	204.76	236.72
Short-Term Debt	129	175	112	-	-	-
Current Portion of Long-Term Debt	127.33	20	-	-	-	-
Current Portion of Leases	1.74	1.95	0.83	1.58	1.34	1.8
Current Income Taxes Payable	22.82	11.54	3.86	-	127.49	96.67
Current Unearned Revenue	37.48	38.37	31.77	41.76	97.3	59.09
Other Current Liabilities	377.53	168.07	444.86	549.35	610.45	95.68
Total Current Liabilities	778.27	569.89	770.32	747.94	1,122	584.26
Long-Term Debt	868.38	842.67	432.36	-	-	-
Long-Term Leases	2.07	2.86	0.2	0.57	1.25	1.2
Long-Term Unearned Revenue	7.45	6.84	4.11	-	-	-
Long-Term Deferred Tax Liabilities	103.81	146	103.81	103.81	103.81	-
Other Long-Term Liabilities	1	1	1	-	-	-
Total Liabilities	1,782	1,591	1,331	869.26	1,248	606.84
Common Stock	1,195	1,195	953.82	953.82	794.85	794.85
Additional Paid-In Capital	2,234	2,234	1,357	1,348	1,348	1,348
Retained Earnings	1,603	1,646	1,373	1,067	1,208	1,309
Comprensive Income & Other	18.4	25.46	-54.73	-48.93	-29.38	22.25
Shareholders' Equity	5,050	5,100	3,629	3,321	3,322	3,475
Total Liabilities & Equity	6,832	6,691	4,961	4,190	4,570	4,081
Total Debt	1,129	1,042	545.38	2.16	2.59	2.99
Net Cash (Debt)	-217.05	-11.42	-281.01	690.48	630.44	1,017
Net Cash Growth	-	-	-	9.52%	-37.98%	28.47%
Net Cash Per Share	-1.88	-0.10	-2.61	6.42	5.84	9.39
Filing Date Shares Outstanding	119.51	119.51	107.3	107.3	107.3	107.3
Total Common Shares Outstanding	119.51	119.51	107.3	107.3	107.3	107.3
Working Capital	1,241	1,383	272.08	649.37	796.6	1,352
Book Value Per Share	42.26	42.67	33.82	30.95	30.96	32.38
Tangible Book Value	5,008	5,054	3,575	3,260	3,281	3,427
Tangible Book Value Per Share	41.91	42.29	33.31	30.38	30.58	31.94
Land	687.88	687.88	687.88	825.68	825.68	825.68
Buildings	722.9	707	700.23	684.47	553.52	737.84
Machinery	2,388	1,786	1,185	577.08	576.8	1,708
Construction In Progress	1,076	1,565	1,323	633.3	222.71	168.43

Source: S&P Capital IQ. Standard template. Financial Sources.